The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
The Brainstem Pathologies of Parkinson's Disease and Dementia with Lewy Bodies
Open accessAbstract
Parkinson's disease ( PD ) and dementia with L ewy bodies ( DLB ) are among the human synucleinopathies, which show alpha‐synuclein immunoreactive neuronal and/or glial aggregations and progressive neuronal loss in selected brain regions (eg, substantia nigra, ventral tegmental area, pedunculopontine nucleus). Despite several studies about brainstem pathologies in PD and DLB , there is currently no detailed information available regarding the presence of alpha‐synuclein immunoreactive inclusions (i) in the cranial nerve, precerebellar, vestibular and oculomotor brainstem nuclei and (ii) in brainstem fiber tracts and oligodendroctyes. Therefore, we analyzed the inclusion pathologies in the brainstem nuclei ( L ewy bodies, LB ; L ewy neurites, LN ; coiled bodies, CB ) and fiber tracts ( LN , CB ) of PD and DLB patients. As reported in previous studies, LB and LN were most prevalent in the substantia nigra, ventral tegmental area, pedunculopontine and raphe nuclei, periaqueductal gray, locus coeruleus, parabrachial nuclei, reticular formation, prepositus hypoglossal, dorsal motor vagal and solitary nuclei. Additionally we were able to demonstrate LB and LN in all cranial nerve nuclei, premotor oculomotor, precerebellar and vestibular brainstem nuclei, as well as LN in all brainstem fiber tracts. CB were present in nearly all brainstem nuclei and brainstem fiber tracts containing LB and/or LN . These findings can contribute to a large variety of less well‐explained PD and DLB symptoms (eg, gait and postural instability, impaired balance and postural reflexes, falls, ingestive and oculomotor dysfunctions) and point to the occurrence of disturbances of intra‐axonal transport processes and transneuronal spread of the underlying pathological processes of PD and DLB along anatomical pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 9×
“From there, the pathology takes an ascending course, reaches select nuclei in the pontomedullary junction (ie, great raphe nucleus and gigantocellular reticular nucleus) and pons (locus coeruleus), then affects the midbrain with the dopaminergic substantia nigra, the basal forebrain, amygdala, thalamus and hypothalamu…”
BackgroundMethodSelf-citationDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807 · cited 5×
“From there, the pathology takes an ascending course, reaches select nuclei in the pontomedullary junction (ie, great raphe nucleus and gigantocellular reticular nucleus) and pons (locus coeruleus), then affects the midbrain with the dopaminergic substantia nigra, the basal forebrain, amygdala, thalamus and hypothalamu…”
BackgroundInfluentialCalabrese, V. P. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490230111048 · Cited by 2,501
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Self-citationGastrointestinal Dysfunction in Parkinson’s Disease
Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., & Pfeiffer, R. F. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00007-1 · Cited by 1,016
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
Litvan, I., Bhatia, K. P., Burn, D. J., Goetz, C. G., Lang, A. E., McKeith, I., Quinn, N., Sethi, K. D., Shults, C., & Wenning, G. K. (2003) · Movement Disorders · doi:10.1002/mds.10459 · Cited by 1,009
Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria
Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., Hardy, J., Leverenz, J. B., Del Tredici, K., Wszolek, Z. K., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70238-8 · Cited by 972
Gastrointestinal dysfunction in Parkinson's disease
Pfeiffer, R. F. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00307-7 · Cited by 925
Prion-like transmission of protein aggregates in neurodegenerative diseases
Brundin, P., Melki, R., & Kopito, R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2873 · Cited by 778
The cerebellum in Parkinson’s disease
Wu, T., & Hallett, M. (2013) · Brain · doi:10.1093/brain/aws360 · Cited by 748
Role of Axonal Transport in Neurodegenerative Diseases
De Vos, K. J., Grierson, A. J., Ackerley, S., & Miller, C. C. J. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.061307.090711 · Cited by 738
Criteria for diagnosing Parkinson's disease
Calne, D. B., Snow, B. J., & Lee, C. (1992) · Annals of Neurology · doi:10.1002/ana.410320721 · Cited by 628
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders
Jucker, M., & Walker, L. C. (2011) · Annals of Neurology · doi:10.1002/ana.22615 · Cited by 622 · cited 2×
“In view of the stereotypical topographic progression throughout the brain and the potential transneuronal spread of neuronal pathologies resulting in characteristic brain distribution patterns, PD and DLB are currently suspected to be among the so-called “prion-like” diseases (2, 9, 13, 20, 26, 31, 36, 59, 63, 66).”
BackgroundThe parkinson's complex: Parkinsonism is just the tip of the iceberg
Langston, J. W. (2006) · Annals of Neurology · doi:10.1002/ana.20834 · Cited by 583
Gibb, W. R., & Lees, A. J. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.5.388 · Cited by 574
The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease
Paulus, W., & Jellinger, K. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00006 · Cited by 554
Prevalence of oropharyngeal dysphagia in Parkinson’s disease: A meta-analysis
Kalf, J. G., de Swart, B. J. M., Bloem, B. R., & Munneke, M. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.11.006 · Cited by 552
THE NEUROLOGY OF EYE MOVEMENTS
Leigh, R. J., & Zee, D. S. (1984) · Optometry and Vision Science · doi:10.1097/00006324-198402000-00014 · Cited by 498
Wenning, G. K., Colosimo, C., Geser, F., & Poewe, W. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00662-8 · Cited by 469
The propagation of prion-like protein inclusions in neurodegenerative diseases
Goedert, M., Clavaguera, F., & Tolnay, M. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.04.003 · Cited by 454
Wakabayashi, K., Hayashi, S., Yoshimoto, M., Kudo, H., & Takahashi, H. (2000) · Acta Neuropathologica · doi:10.1007/pl00007400 · Cited by 441
OCULAR MOTOR DEFICITS IN PARKINSON'S DISEASE: II. CONTROL OF THE SACCADIC AND SMOOTH PURSUIT SYSTEMS
WHITE, O. B., SAINT-CYR, J. A., TOMLINSON, R. D., & SHARPE, J. A. (1983) · Brain · doi:10.1093/brain/106.3.571 · Cited by 406
Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization
German, D. C., Manaye, K., Smith, W. K., Woodward, D. J., & Saper, C. B. (1989) · Annals of Neurology · doi:10.1002/ana.410260403 · Cited by 396
Irizarry, M. C., Growdon, W., Gomez-isla, T., Newell, K., George, J. M., Clayton, D. F., & Hyman, B. T. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199804000-00005 · Cited by 394
Central vestibular system: vestibular nuclei and posterior cerebellum
Barmack, N. H. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00055-8 · Cited by 392
The pedunculopontine nucleus in Parkinson's disease
Zweig, R. M., Jankel, W. R., Hedreen, J. C., Mayeux, R., & Price, D. L. (1989) · Annals of Neurology · doi:10.1002/ana.410260106 · Cited by 386
A critical evaluation of the Braak staging scheme for Parkinson's disease
Burke, R. E., Dauer, W. T., & Vonsattel, J. P. G. (2008) · Annals of Neurology · doi:10.1002/ana.21541 · Cited by 377
Axonal transport defects: a common theme in neurodegenerative diseases
Roy, S., Zhang, B., Lee, V. M.-Y., & Trojanowski, J. Q. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0952-x · Cited by 372
The basal ganglia in Parkinson's disease: Current concepts and unexplained observations
Obeso, J. A., Marin, C., Rodriguez-Oroz, C., Blesa, J., Benitez-Temiño, B., Mena-Segovia, J., Rodríguez, M., & Olanow, C. W. (2009) · Annals of Neurology · doi:10.1002/ana.21481 · Cited by 359 · cited 2×
“The progressive loss of dopaminergic neurons in the compact part of the substantia nigra and the widespread occurrence of alpha-synuclein immunoreactive LB and LN in the central and peripheral nervous system are currently considered as the neuropathological hallmarks of PD (6, 8, 15, 19, 24, 28, 29, 32, 34, 35, 38, 39…”
BackgroundNeuropathological spectrum of synucleinopathies
Jellinger, K. A. (2003) · Movement Disorders · doi:10.1002/mds.10557 · Cited by 340
Multiple system atrophy: A primary oligodendrogliopathy
Wenning, G. K., Stefanova, N., Jellinger, K. A., Poewe, W., & Schlossmacher, M. G. (2008) · Annals of Neurology · doi:10.1002/ana.21465 · Cited by 324
The prion hypothesis in Parkinson's disease: braak to the future
Visanji, N. P., Brooks, P. L., Hazrati, L.-N., & Lang, A. E. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-2 · Cited by 278
The neuropathology, pathophysiology and genetics of multiple system atrophy
Ahmed, Z., Asi, Y. T., Sailer, A., Lees, A. J., Houlden, H., Revesz, T., & Holton, J. L. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01234.x · Cited by 274
CLINICAL AND PATHOLOGICAL FEATURES OF DIFFUSE CORTICAL LEWY BODY DISEASE (LEWY BODY DEMENTIA)
GIBB, W. R. G., ESIRI, M. M., & LEES, A. J. (1987) · Brain · doi:10.1093/brain/110.5.1131 · Cited by 260
Are synucleinopathies prion-like disorders?
Angot, E., Steiner, J. A., Hansen, C., Li, J.-Y., & Brundin, P. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70213-1 · Cited by 251
A critical evaluation of current staging of α-synuclein pathology in Lewy body disorders
Jellinger, K. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.07.006 · Cited by 232
A critical reappraisal of current staging of Lewy-related pathology in human brain
Jellinger, K. A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0406-y · Cited by 230
Pedunculopontine nucleus: Functional organization and clinical implications
Benarroch, E. E. (2013) · Neurology · doi:10.1212/wnl.0b013e3182886a76 · Cited by 183
A deadly spread: cellular mechanisms of α-synuclein transfer
Steiner, J. A., Angot, É., & Brundin, P. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.53 · Cited by 176
Costanzo, M., & Zurzolo, C. (2013) · Biochemical Journal · doi:10.1042/bj20121898 · Cited by 174
Impaired vertical postural control and proprioceptive integration deficits in Parkinson’s disease
Vaugoyeau, M., Viel, S., Assaiante, C., Amblard, B., & Azulay, J. P. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.01.052 · Cited by 170
Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts
Fellner, L., Jellinger, K. A., Wenning, G. K., & Stefanova, N. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0833-z · Cited by 162
Brainstem pathology and non-motor symptoms in PD
Grinberg, L. T., Rueb, U., Alho, A. T. D. L., & Heinsen, H. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.021 · Cited by 162
Self-citationInvolvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease
Benarroch, E. E., Schmeichel, A. M., Sandroni, P., Low, P. A., & Parisi, J. E. (2006) · Neurology · doi:10.1212/01.wnl.0000196638.98781.bb · Cited by 146
Specific A10 Dopaminergic Nuclei in the Midbrain Degenerate in Parkinson's Disease
McRitchie, D. A., Cartwright, H., & Halliday, G. M. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6418 · Cited by 138
α‐Synuclein: The Long Distance Runner
George, S., Rey, N. L., Reichenbach, N., Steiner, J. A., & Brundin, P. (2013) · Brain Pathology · doi:10.1111/bpa.12046 · Cited by 135
Murray, A. M., Weihmueller, F. B., Marshall, J. F., Hurtig, H. I., Gottleib, G. L., & Joyce, J. N. (1995) · Annals of Neurology · doi:10.1002/ana.410370306 · Cited by 135
Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy
Schmeichel, A. M., Buchhalter, L. C., Low, P. A., Parisi, J. E., Boeve, B. F., Sandroni, P., & Benarroch, E. E. (2008) · Neurology · doi:10.1212/01.wnl.0000298691.71637.96 · Cited by 121
Weisman, D., & McKeith, I. G. (2007) · Seminars in Neurology · doi:10.1055/s-2006-956754 · Cited by 120
Swallowing, ingestion and dysphagia: a reappraisal.
Leopold, N. A., & Kagel, M. C. (1983) · PubMed · Cited by 112
First appraisal of brain pathology owing to A30P mutant alpha‐synuclein
Seidel, K., Schöls, L. J., Nuber, S., Petrasch‐Parwez, E., Gierga, K., Wszołek, Z. K., Dickson, D. W., Gai, W., Bornemann, A., Rieß, O., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21966 · Cited by 110
Self-citationDementia with Lewy bodies and Parkinson's disease
McKeith, I. G., & Mosimann, U. P. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2003.12.005 · Cited by 109
Smithson, K. G., MacVicar, B. A., & Hatton, G. I. (1983) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(83)90016-x · Cited by 105
Multiple System Atrophy: Pathophysiology and Management
Wenning, G. K., & Braune, S. (2001) · CNS Drugs · doi:10.2165/00023210-200115110-00003 · Cited by 104
Beyond α-synuclein transfer: pathology propagation in Parkinson's disease
Hansen, C., & Li, J. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.03.002 · Cited by 103
Vitale, C., Marcelli, V., Furia, T., Santangelo, G., Cozzolino, A., Longo, K., Allocca, R., Amboni, M., Marciano, E., & Barone, P. (2011) · Movement Disorders · doi:10.1002/mds.23657 · Cited by 102
Brainstem: Neglected Locus in Neurodegenerative Diseases
Grinberg, L. T., Rueb, U., & Heinsen, H. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00042 · Cited by 102
Self-citationDegeneration of ingestion‐related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7
Rüb, U., Brunt, E. R. P., Petrasch‐Parwez, E., Schöls, L. J., Theegarten, D., Auburger, G. W. J., Seidel, K., Schultz, C., Gierga, K., Paulson, H. L., et al. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00772.x · Cited by 100
Self-citationInvolvement of precerebellar nuclei in multiple system atrophy
Braak, H., Rüb, U., & Tredici, K. D. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00432.x · Cited by 94
Self-citationGerrits, N. M. (1990) · Elsevier eBooks · doi:10.1016/b978-0-12-547625-6.50031-3 · Cited by 85
α-Synuclein Accumulates in Purkinje Cells in Lewy Body Disease but not in Multiple System Atrophy
Mori, F., Piao, Y.-S., Hayashi, S., Fujiwara, H., Hasegawa, M., Yoshimoto, M., Iwatsubo, T., Takahashi, H., & Wakabayashi, K. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.8.812 · Cited by 79
The Role of Glia in Alpha-Synucleinopathies
Fellner, L., & Stefanova, N. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8340-3 · Cited by 77
Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disorders
Krüger, R., Müller, T., & Rieß, O. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050002 · Cited by 72
Self-citationRüb, U., Brunt, E. R. P., de Vos, R. A. I., Turco, D. D., Tredici, K. D., Gierga, K., Schultz, C., Ghebremedhin, E., Bürk, K., Auburger, G. W. J., et al. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00554.x · Cited by 71
Self-citationα-Synuclein pathology affecting Bergmann glia of the cerebellum in patients with α-synucleinopathies
Piao, Y.-S., Mori, F., Hayashi, S., Tanji, K., Yoshimoto, M., Kakita, A., Wakabayashi, K., & Takahashi, H. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0655-0 · Cited by 66
Rüb, U., Gierga, K., Brunt, E. R. P., de Vos, R. A. I., Bauer, M., Schöls, L. J., Bürk, K., Auburger, G. W. J., Bohl, J. R. E., Schultz, C., et al. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0287-3 · Cited by 63
Self-citationSubstance P-containing neurons in the pontomesencephalic tegmentum of the human brain
Halliday, G. M., Gai, W. P., Blessing, W. W., et al. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90223-q · Cited by 41
Rüb, U., Heinsen, H., Brunt, E. R. P., Landwehrmeyer, G. B., den Dunnen, W. F. A., Gierga, K., & Deller, T. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00994.x · Cited by 33
Self-citationDementia With Cerebral Lewy Bodies: A Mesocortical Dopaminergic Defect?
Eggertson, D. E., & Sima, A. A. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520050094034 · Cited by 33
Goto, S., & Hirano, A. (1991) · Annals of Neurology · doi:10.1002/ana.410300211 · Cited by 28
Tau-negative astrocytic star-like inclusions and coiled bodies in dementia with Lewy bodies
Terada, S., Ishizu, H., Haraguchi, T., Takehisa, Y., Tanabe, Y., Kawai, K., & Kuroda, S. (2000) · Acta Neuropathologica · doi:10.1007/s004010000213 · Cited by 21
Rüb, U., Jen, J. C., Braak, H., & Deller, T. (2008) · Experimental Brain Research · doi:10.1007/s00221-008-1342-8 · Cited by 18
Self-citationDementia with Lewy Bodies: Clinical Characteristics and Diagnostic Criteria
Walker, Z., Medicine, D. G., & Stevens, T. (2002) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870201500403 · Cited by 9
Does a prion-like mechanism play a major role in the apparent spread of α-synuclein pathology?
Sacino, A. N., & Giasson, B. I. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt151 · Cited by 7
Cited by
Circuit Mechanisms of Parkinson’s Disease
McGregor, M. M., & Nelson, A. B. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.004 · Cited by 624
Kamath, T., Abdulraouf, A., Burris, S. J., Langlieb, J., Gazestani, V., Nadaf, N. M., Balderrama, K., Vanderburg, C., & Macosko, E. Z. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01061-1 · Cited by 552
Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases
Chi, H., Chang, H.-Y., & Sang, T.-K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103082 · Cited by 412
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
Jellinger, K. A., & Korczyn, A. D. (2018) · BMC Medicine · doi:10.1186/s12916-018-1016-8 · Cited by 385
Bryois, J., Skene, N. G., Hansen, T. F., Kogelman, L. J. A., Watson, H. J., Liu, Z., Eating Disorders Working Group of the Psychiatric Genomics Consortium, Adan, R., Alfredsson, L., Ando, T., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0610-9 · Cited by 366
Metadata
- Authors
- Seidel, K., Mahlke, J., Siswanto, S., Krüger, R., Heinsen, H., Auburger, G., Bouzrou, M., Grinberg, L. T., Wicht, H., Korf, H., den Dunnen, W., & Rüb, U.
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2014-09-12
- Volume
- 25
- Issue
- 2
- Pages
- 121-135
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- OpenAlex
- W2145799888
- Cited by
- 306
- References
- 77
- FWCI
- 10.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.